Zedsen is a UK-based startup striving to revolutionize health and oncological care with its proprietary non-invasive sensor technology. The company is committed to addressing the Institute for Healthcare Improvement’s "Triple Aim" by enhancing care quality, improving overall patient health, and reducing healthcare costs. Founded in 2014, Zedsen operates within the biotechnology, healthcare, and lifestyle industries.
The startup recently secured a significant $12.00M Series B investment on 06 April 2021. This round saw participation from investors including Tony Rice, Nasser J. Kazeminy, James W. Harpel, Bonnie McElveen Hunter, and Joseph Grano. With a focus on non-invasive technology, Zedsen is poised to make a substantial impact in the healthcare sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $12.00M | 5 | Tony Rice, Nasser J. Kazeminy +3 | 06 Apr 2021 |
No recent news or press coverage available for Zedsen.